On a conference call with analysts, Gilead walked through how a string of recent deals focused on cancer and autoimmune ...

Renovare Therapeutics, Inc., a privately-held biotechnology company pioneering regenerative therapeutics for osteoarthritis, today announced its formal launch from stealth mode and collaboration with ...

"Section 232" national security levies won't apply to a wide array of drugs, meaning the "overall threat to the sector should ...

The South Korean biotech company had previously announced it would purchase and expand one plant for $280 million.

Colorado drugmaker Ambrosia Biosciences has landed $100 million to pursue an oral obesity drug it’s hoping can compete with a ...

Zee Business provides the latest business news such as Indian stock market news and Updates, sensex live news & nifty news. Check out the personal finance news from the world of business including BSE ...

In this interview, Dr. Michelle Fraser highlights how base editing and AI-designed enzymes are expanding therapeutic ...

March 24 (Reuters) - Spanish drugmaker Grifols (GRLS.MC), opens new tab said on Tuesday it has approved a U.S. initial ‌public offering of its U.S. biopharma business. Grifols, which makes drugs using ...

TORONTO, March 10, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma ” or the “Company ”), is pleased to announce that it will release its ...

Biliary Tract Cancer Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced the appointment of John A. Orwin as Chair of its Board of Directors. Mr. Orwin ...

Synthekine Inc., an engineered cytokine therapeutics company, today announced the appointment of John A. Orwin as Chair of its Board of Directors. Mr. Orwin succeeds Srinivas Akkaraju, M.D., Ph.D., ...